Gut microbiota and metabolic syndrome

doi:10.3748/wjg.v20.i43.16079

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 43

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (23201)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-5) series.

Item

Count

PDF

2625

WORD

511

HTML

17124

Tables (1-5)

165

Sum=20425

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1291

Download

1485

Sum=2776

Nov 21, 2014 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (367)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Nov 21, 2014; 20(43): 16079-16094
Published online Nov 21, 2014. doi: 10.3748/wjg.v20.i43.16079

Table 1 Studies conducted on animal models showing effects of probiotics containing Bifidobacterium strains on metabolic disorders

Studied animals	Probiotic	Dose	Duration of treatment (wk)	Effects	Ref.
C57BL/6J mice	Bifidobacterium breve B-3	10⁹ CFU	8	↓body weight, epididymal fat, serum cholesterol, glucose, insulin and HOMA index	[99]
C57BL/6J mice	Bifidobacterium breve B-3	10⁹ CFU	8	↑expression of FIAF, adiponectin	[99]
C57BL-6 mice	Bifidobacterium pseudocatenulatum CECT 7765		7	↓serum cholesterol, triglycerides, glucose, insulin resistance, leptin, IL-6, monocyte chemotactic protein-1, liver steatosis, adipose tissue	[100]
C57BL-6 mice	Bifidobacterium pseudocatenulatum CECT 7765		7	↑glucose tolerance	[100]
				Improvement of immune system functionality
HFD-fed rats	Bifidobacterium longum			Improvement of HFD induced metabolic disorders trough ↓endotoxin levels and intestinal inflammation, ↑expression of Reg I genes	[101]
HFD-rats, standard diets fed rats	Bifidobacterium adolescentis		12	↓visceral fat, liver steatosis	[102]
HFD-rats, standard diets fed rats	Bifidobacterium adolescentis		12	↑insulin sensitivity	[102]
Sprague-Dawley rats	B. pseudocatenulatum SPM 1204, B. longum SPM 1205, and B. longum SPM 1207	10⁸-10⁹ CFU	7	↓body and fat weights, serum cholesterol, triglycerides, glucose, leptin, AST, ALT and lipase levels	[103]
Sprague-Dawley rats	Bifidobacteria L66-5, L75-4, M13-4 and FS31-12, originated from normal human intestines	10⁸ CFU	6	B. M13-4 strain ↑body weight	[104]
				B. L66-5 strain ↓body weight
				All strains ↓serum and liver triglycerides, serum and liver cholesterol

CFU: Colony-forming units; IL-6: Interleukin-6; HFD: High-fat diet; Reg I genes: Intestinal regenerating family genes; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; FIAF: Fasting-induced adipose factor; HFD: High-fat diet.

Citation: Festi D, Schiumerini R, Eusebi LH, Marasco G, Taddia M, Colecchia A. Gut microbiota and metabolic syndrome. World J Gastroenterol 2014; 20(43): 16079-16094
URL: https://www.wjgnet.com/1007-9327/full/v20/i43/16079.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i43.16079